Latest News about MRK
Recent news which mentions MRK
From Benzinga
Bear Market: 2 Safe Stocks to Buy Right Now
September 28, 2022
From Motley Fool
7 Blue-Chip Sleeper Stocks to Buy Before Wall Street Wakes Up
September 28, 2022
From InvestorPlace
Corvus Pharma's Partner Secures China Approval For Early-Stage Mupadolimab Trial For Lung, Head & Neck Cancer
September 27, 2022
From Benzinga
7 Dow Sleeper Stocks to Buy Before Wall Street Wakes Up
September 26, 2022
From InvestorPlace
A Stock's Price "Tells You Almost Nothing"
September 24, 2022
From Motley Fool
From Benzinga
My Take: 4 Strong Growth Stocks to Buy This Week
September 23, 2022
From Motley Fool
Citius Pharma Inks Clinical Collaboration For I/ONTAK Combo Regime in Solid Tumor Settings
September 23, 2022
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
September 22, 2022
From Benzinga
Nanobiotix Establishes Recommended Dose For Registrational Study Of Head & Neck Combo Therapy Trial
September 22, 2022
From Benzinga
Why Is Evaxion Biotech (EVAX) Stock Up Today?
September 21, 2022
From InvestorPlace
3 Best Dow Jones Stocks of 2022 So Far: Are They Buys Now?
September 21, 2022
From Motley Fool
3 Stocks That Could Rocket on Biden’s Cancer Moonshot
September 20, 2022
From InvestorPlace
Merck To Start New Islatravir HIV Trials With Lower Dose After FDA Hold
September 20, 2022
From Benzinga
Take-Two Gets Beat Down After Leak of Its Popular Grand Theft Auto VI
September 19, 2022
From Benzinga
7 Penny Stocks That Actually Have a Buy Rating
September 19, 2022
From InvestorPlace
Why Hedge Funds Are Piling In These 2 High Yielding Stocks
September 18, 2022
From Benzinga
7 Undervalued Stock Picks to Beat the September Market Slump
September 16, 2022
From InvestorPlace
Why This Monster Stock's Recent Blunders Might Not Matter
September 15, 2022
Tickers
MRK
From Motley Fool
2 Healthcare Stocks That Could Help Set You Up for Life
September 15, 2022
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2022
September 14, 2022
From Benzinga
Immutep Issues Development Update For Its Lead Cancer Candidate
September 14, 2022
From Benzinga
Evercore ISI Group Boosts PT On This Stock By Around 400%, Plus This Analyst Predicts $100 For Merck
September 14, 2022
From Benzinga
AstraZeneca, Eli Lilly and Roche among pharmaceutical companies upgraded for high returns on R&D investments, analysts say
September 14, 2022
From MarketWatch
Important Biotech Catalysts For September 13, 2022 - End Of The Day Summary
September 13, 2022
From Benzinga
Merck Secures Canadian Regulatory Nod For KEYTRUDA In Skin Cancer After Resection
September 13, 2022
Tickers
MRK
From Benzinga
After FDA Regulatory Setback, Penny Stock ObsEva Cuts 70% Of Its Staff
September 13, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.